Survival in young patients with intermediate-/high-risk myelofibrosis: Estimates derived from databases for non transplant patients-Reference-Cited by-同舟云学术

Survival in young patients with intermediate-/high-risk myelofibrosis: Estimates derived from databases for non transplant patients

Published:2009-03 Issue:3 Volume:84 Page:140-143
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Siragusa Sergio,Passamonti Francesco,Cervantes Francisco,Tefferi Ayalew

Publisher

Wiley

Subject

Hematology

Reference23 articles.

1. Validation and comparison of contemporary prognostic models in primary myelofibrosis: Analysis based on 334 patients from a single institution;Tefferi;Cancer,2007

2. Choosing between stem cell therapy and drugs in myelofibrosis;Kroger;Leukemia,2008

3. Prognosis in transplant-eligible patients with agnogenic myeloid metaplasia: A simple CBC-based scoring system;Dingli;Cancer,2006

4. Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: A European group for blood and marrow transplantation, Societe Francaise de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center collaborative study;Guardiola;Blood,1999

5. Myelofibrosis with myeloid metaplasia;Guardiola;N Engl J Med,2000

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic Stem Cell Transplantation Combined With Transfusion of Mesenchymal Stem Cells in Primary Myelofibrosis: A Multicenter Retrospective Study;Frontiers in Oncology;2022-01-24

2. Allogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: a report from the MPN Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation;Haematologica;2014-01-03

3. Emerging drugs for myelofibrosis;Expert Opinion on Emerging Drugs;2012-11-28

4. BCR-ABL1-negative chronic myeloid neoplasms: an update on management techniques;Future Oncology;2012-05

5. Dynamic International Prognostic Scoring System scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis;Haematologica;2012-04-04